According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy at Minnesota Oncology, discusses how the prospect of patient ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...

Prolonged immigration detention is significantly associated with worsened self-rated health, along with high rates of ...